|
1
|
Yoshpe-Purer Y and Eylan E: Disinfection
of water by hydrogen peroxide. Health Lab Sci. 5:233–238.
1968.PubMed/NCBI
|
|
2
|
Tauber AI and Babior BM: Evidence for
hydroxyl radical production by human neutrophils. J Clin Invest.
60:374–379. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosen H and Klebanoff SJ: Bactericidal
activity of a superoxide anion-generating system. A model for the
polymorphonuclear leukocyte. J Exp Med. 149:27–39. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sawyer DT and Tsang PK: The interactions
of superoxide ion (O2-.) with metallo-porphyrins [(C1(8)TPP)M,
M=Fe, Mn, Co Zn]; models for biological systems and superoxide
dismutases. Free Radic Res Commun. 12–13:75–86. 1991. View Article : Google Scholar
|
|
5
|
Dreher D and Junod AF: Differential
effects of superoxide, hydrogen peroxide and hydroxyl radical on
intracellular calcium in human endothelial cells. J Cell Physiol.
162:147–153. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Landriscina M, Maddalena F, Laudiero G and
Esposito F: Adaptation to oxidative stress, chemoresistance, and
cell survival. Antioxid Redox Signal. 11:2701–2716. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cross CE, Halliwell B, Borish ET, Pryor
WA, Ames BN, Saul RL, McCord JM and Harman D: Oxygen radicals and
human disease. Ann Intern Med. 107:526–545. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klaunig JE, Wang Z, Pu X and Zhou S:
Oxidative stress and oxidative damage in chemical carcinogenesis.
Toxicol Appl Pharmacol. 254:86–99. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weinberg F and Chandel NS: Reactive oxygen
species-dependent signaling regulates cancer. Cell Mol Life Sci.
66:3663–3673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mercuro G, Cadeddu C, Piras A, Dessì M,
Madeddu C, Deidda M, Serpe R, Massa E and Mantovani G: Early
epirubicin-induced myocardial dysfunction revealed by serial tissue
Doppler echocardiography: Correlation with inflammatory and
oxidative stress markers. Oncologist. 12:1124–1133. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cadeddu C, Piras A, Mantovani G, Deidda M,
Dessì M, Madeddu C, Massa E and Mercuro G: Protective effects of
the angiotensin II receptor blocker telmisartan on
epirubicin-induced inflammation, oxidative stress, and early
ventricular impairment. Am Heart J. 160:487.e1–e7. 2010. View Article : Google Scholar
|
|
13
|
Minotti G, Menna P, Salvatorelli E, Cairo
G and Gianni L: Anthracyclines: Molecular advances and
pharmacologic developments in antitumor activity and
cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang J, Nakamura H and Iyer AK:
Tumor-targeted induction of oxystress for cancer therapy. J Drug
Target. 15:475–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamada T, Egashira N, Imuta M, Yano T,
Yamauchi Y, Watanabe H and Oishi R: Role of oxidative stress in
vinorelbine-induced vascular endothelial cell injury. Free Radic
Biol Med. 48:120–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DeLoughery Z, Luczak MW and Zhitkovich A:
Monitoring Cr intermediates and reactive oxygen species with
fluorescent probes during chromate reduction. Chem Res Toxicol.
27:843–851. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okamura DM, Bahrami NM, Ren S, Pasichnyk
K, Williams JM, Gangoiti JA, Lopez-Guisa JM, Yamaguchi I, Barshop
BA, Duffield JS and Eddy AA: Cysteamine modulates oxidative stress
and blocks myofibroblast activity in CKD. J Am Soc Nephrol.
25:43–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ting CH, Huang HN, Huang TC, Wu CJ and
Chen JY: The mechanisms by which pardaxin, a natural cationic
antimicrobial peptide, targets the endoplasmic reticulum and
induces c-FOS. Biomaterials. 35:3627–3640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao G, Alessio HM and Cutler RG:
Oxygen-radical absorbance capacity assay for antioxidants. Free
Radic Biol Med. 14:303–311. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao G, Verdon CP, Wu AH, Wang H and Prior
RL: Automated assay of oxygen radical absorbance capacity with the
COBAS FARA II. Clin Chem. 41:1738–1744. 1995.PubMed/NCBI
|
|
21
|
Ou B, Hampsch-Woodill M and Prior RL:
Development and validation of an improved oxygen radical absorbance
capacity assay using fluorescein as the fluorescent probe. J Agric
Food Chem. 49:4619–4626. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dávalos A, Gómez-Cordovés C and Bartolomé
B: Extending applicability of the oxygen radical absorbance
capacity (ORAC-fluorescein) assay. J Agric Food Chem. 52:48–54.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang D, Ou B and Prior RL: The chemistry
behind antioxidant capacity assays. J Agric Food Chem.
53:1841–1856. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jomova K and Valko M: Advances in
metal-induced oxidative stress and human disease. Toxicology.
283:65–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gupte A and Mumper RJ: Elevated copper and
oxidative stress in cancer cells as a target for cancer treatment.
Cancer Treat Rev. 35:32–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawashima T, Manda S, Uto Y, Ohkubo K,
Hori H, Matsumoto K, Fukuhara K, Ikota N, Fukuzumi S, Ozawa T, et
al: Kinetics and mechanism for the scavenging reaction of the
2,2-diphenyl-1-picrylhydrazyl radical by synthetic artepillin C
analogues. Bull Chem Soc Jpn. 85:877–883. 2012. View Article : Google Scholar
|
|
27
|
Tewey KM, Rowe TC, Yang L, Halligan BD and
Liu LF: Adriamycin-induced DNA damage mediated by mammalian DNA
topoisomerase II. Science. 226:466–468. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vrdoljak AL, Berend S, Zeljezić D,
Piljac-Zegarac J, Plestina S, Kuca K, Radić B, Mladinić M and
Kopjar N: Irinotecan side effects relieved by the use of HI-6
oxime: In vivo experimental approach. Basic Clin Pharmacol Toxicol.
105:401–409. 2009. View Article : Google Scholar : PubMed/NCBI
|
